A detailed history of Advisor Group Holdings, Inc. transactions in Immunovant, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 2,263 shares of IMVT stock, worth $62,255. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,263
Previous 1,585 42.78%
Holding current value
$62,255
Previous $41,000 51.22%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$27.51 - $27.51 $18,651 - $18,651
678 Added 42.78%
2,263 $62,000
Q2 2024

Aug 13, 2024

BUY
$25.1 - $31.61 $1,606 - $2,023
64 Added 4.21%
1,585 $41,000
Q1 2024

May 10, 2024

SELL
$30.27 - $43.79 $73,313 - $106,059
-2,422 Reduced 61.43%
1,521 $49,000
Q4 2023

Feb 12, 2024

BUY
$31.31 - $44.19 $31,779 - $44,852
1,015 Added 34.67%
3,943 $166,000
Q3 2023

Nov 13, 2023

SELL
$18.55 - $39.96 $1,335 - $2,877
-72 Reduced 2.4%
2,928 $112,000
Q1 2022

May 04, 2022

SELL
$5.06 - $8.77 $283 - $491
-56 Reduced 1.83%
3,000 $17,000
Q3 2021

Nov 05, 2021

BUY
$7.01 - $11.37 $21,422 - $34,746
3,056 New
3,056 $26,000
Q1 2021

May 13, 2021

SELL
$13.08 - $49.6 $340 - $1,289
-26 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$22.61 - $38.9 $587 - $1,011
26 New
26 $1,000

Others Institutions Holding IMVT

About Immunovant, Inc.


  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.